Klostenal

Beclometasone Dipropionate, the active ingredient in Klostenal, is a corticosteroid presented as a rectal formulation for rectal use. It is employed to treat inflammatory bowel disease and proctitis in adult patients, helping to reduce local inflammation and related symptoms through glucocorticoid receptor activation.

GNH USA supplies Klostenal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to European Union regulatory standards for quality and safety. The product is manufactured under strict GMP conditions and is distributed to multiple continents.

Beclometasone Dipropionate in Klostenal is used to manage inflammatory conditions of the lower gastrointestinal tract.

- Inflammatory bowel disease: reduces rectal inflammation and alleviates abdominal pain, diarrhea, and bleeding. - Proctitis: diminishes mucosal swelling, bleeding, and urgency, promoting symptom relief. - Distal ulcerative colitis: helps achieve remission of lesions confined to the rectum and sigmoid colon.

Beclometasone Dipropionate may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Rectal irritation or burning. - Itching at the site. - Mild abdominal cramping. - Headache.

Serious or Rare Side Effects: - Adrenal suppression with prolonged therapy. - Severe allergic reaction (rash, swelling, anaphylaxis). - Rectal bleeding or ulceration. - Systemic effects such as hyperglycemia or increased infection risk.

When using Klostenal, several precautions should be observed to minimize risks and ensure safe therapy.

- Pregnancy: consult a healthcare professional before use. - Infection: avoid or treat active infections prior to initiating therapy. - Systemic absorption: limit duration to reduce risk of systemic corticosteroid effects. - Children: use with caution; monitor growth and adrenal function. - Hypersensitivity: discontinue if signs of allergic reaction occur. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Beclometasone Dipropionate can interact with other medicines, affecting its safety or efficacy.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase systemic exposure. - Concurrent systemic glucocorticoids can cause additive adrenal suppression. - Live vaccines may have reduced effectiveness.

Moderate Interactions (Monitor Closely): - NSAIDs may raise the risk of gastrointestinal ulceration. - Antidiabetic agents may require dose adjustment due to altered glucose control. - Anticoagulants may increase bleeding tendency when rectal mucosa is irritated.